ORBIMED ADVISORS LLC 13D and 13G filings for 89bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-16 4:25 pm Sale | 2023-05-15 | 13D | 89bio, Inc. ETNB | ORBIMED ADVISORS LLC | 3,777,778 4.800% | -482,913 (-11.33%) | Filing |
| 2023-03-24 4:43 pm Sale | 2023-03-22 | 13D | 89bio, Inc. ETNB | ORBIMED ADVISORS LLC | 0 0.000% | -1,504,436 (Position Closed) | Filing |
| 2023-01-26 4:40 pm Sale | 2023-01-24 | 13D | 89bio, Inc. ETNB | ORBIMED ADVISORS LLC | 1,504,436 3.200% | -325,000 (-17.77%) | Filing |
| 2022-12-27 4:25 pm Sale | 2022-12-22 | 13D | 89bio, Inc. ETNB | ORBIMED ADVISORS LLC | 4,260,691 5.600% | -767,483 (-15.26%) | Filing |
| 2022-08-12 2:29 pm Purchase | 2022-08-10 | 13D | 89bio, Inc. ETNB | ORBIMED ADVISORS LLC | 5,028,174 6.900% | 5,028,174 (New Position) | Filing |
| 2022-07-05 4:30 pm Sale | 2022-07-05 | 13D | 89bio, Inc. ETNB | ORBIMED ADVISORS LLC | 1,829,436 4.700% | -35,285 (-1.89%) | Filing |
| 2020-09-23 5:00 pm Sale | 2020-09-21 | 13D | 89bio, Inc. ETNB | ORBIMED ADVISORS LLC | 1,864,721 9.400% | -137,500 (-6.87%) | Filing |
| 2020-07-13 4:20 pm Unchanged | 2020-07-10 | 13D | 89bio, Inc. ETNB | ORBIMED ADVISORS LLC | 2,002,221 11.900% | 0 (Unchanged) | Filing |